Virtual Screening Approach to Identifying a Novel and Tractable Series of
Journal
ACS medicinal chemistry letters
ISSN: 1948-5875
Titre abrégé: ACS Med Chem Lett
Pays: United States
ID NLM: 101521073
Informations de publication
Date de publication:
11 Feb 2021
11 Feb 2021
Historique:
received:
16
10
2020
accepted:
12
01
2021
entrez:
19
2
2021
pubmed:
20
2
2021
medline:
20
2
2021
Statut:
epublish
Résumé
Novel therapies are required to treat chronic bacterial infections in cystic fibrosis (CF) sufferers. The most common pathogen responsible for these infections is
Identifiants
pubmed: 33603968
doi: 10.1021/acsmedchemlett.0c00554
pmc: PMC7883467
doi:
Types de publication
Journal Article
Langues
eng
Pagination
217-227Informations de copyright
© 2021 American Chemical Society.
Déclaration de conflit d'intérêts
The authors declare no competing financial interest.
Références
Antimicrob Agents Chemother. 2011 Jun;55(6):2670-8
pubmed: 21444693
ChemMedChem. 2016 Jan 5;11(1):15-21
pubmed: 26603496
J Med Chem. 2004 Mar 25;47(7):1739-49
pubmed: 15027865
Respir Med. 2017 Jul;128:1-6
pubmed: 28610665
Chem Commun (Camb). 2013 Apr 21;49(31):3197-9
pubmed: 23482955
J Cyst Fibros. 2007 Jan;6(1):57-65
pubmed: 16870510
J Med Chem. 2000 Feb 10;43(3):305-41
pubmed: 10669559
Jpn J Exp Med. 1978 Feb;48(1):81-4
pubmed: 97425
Front Microbiol. 2019 Aug 02;10:1701
pubmed: 31428062
ACS Med Chem Lett. 2012 Aug 9;3(8):668-672
pubmed: 23181168
Sci Rep. 2015 Apr 23;5:9936
pubmed: 25905792
J Med Chem. 2007 Jan 11;50(1):74-82
pubmed: 17201411
J Comput Aided Mol Des. 2013 Mar;27(3):221-34
pubmed: 23579614
Clin Microbiol Rev. 2011 Jan;24(1):29-70
pubmed: 21233507
J Med Chem. 1989 Aug;32(8):1988-96
pubmed: 2666669
Chem Biol. 2015 Apr 23;22(4):483-491
pubmed: 25892201
Eur J Clin Microbiol Infect Dis. 2013 Oct;32(10):1231-52
pubmed: 23619573
Chem Biol Drug Des. 2006 May;67(5):370-2
pubmed: 16784462
BMC Med. 2011 Apr 04;9:32
pubmed: 21463524